BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
jenburkt pharmaceuticals ltd. stock

JENBURKT PHARMACEUTICALS LTD. Share Price

1324 -1.59 (-0.11%)
Dec 13 2024 03:29 PM Pharmaceuticals NSE: JENBURPH

JENBURKT PHARMACEUTICALS LTD. Share Price Update

As of the latest trading session, JENBURKT PHARMACEUTICALS LTD. share price is currently at 1324, which is down by -1.59 from its previous closing. Today, the stock has fluctuated between 1250.00 and 1324.95. Over the past year, JENBURKT PHARMACEUTICALS LTD. has achieved a return of 92.39 %. In the last month alone, the return has been 11.62 %. Read More...

JENBURKT PHARMACEUTICALS LTD. Performance

Day Range

Low1250.00 High1324.95
1312.30

52 Week Range

Low 643.20 High 1375.00
1312.30

JENBURKT PHARMACEUTICALS LTD. Share Price

524731

JENBURPH

img img img img
No Data Available

Open Price

1300.10

Prev. Close

1325.60

Volume (Shares)

4526.00

Total traded value

58.79

Upper Circuit

1590.70

Lower Circuit

1060.50

Note: The current prices & values are delayed, Login to your account for live updates.

JENBURKT PHARMACEUTICALS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 579.20
PE Ratio (TTM) 19.11
Book Value / Share 357.46
Beta 0.75
ROE 19.44%
EPS (TTM) 68.66
Dividend Yield 1.17%
Net Profit Qtr (Cr) 9.60

JENBURKT PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 41.22
Operating Expense 30.55
Net Profit 9.60
Net Profit Margin (%) 23.28
Earnings Per Share (EPS) 21.75
EBITDA 13.28
Effective Tax Rate (%) 23.32
Particulars JUN 2024 (Values in Cr)
Revenue 32.54
Operating Expense 23.88
Net Profit 7.42
Net Profit Margin (%) 22.80
Earnings Per Share (EPS) 16.80
EBITDA 10.69
Effective Tax Rate (%) 26.34
Particulars MAR 2024 (Values in Cr)
Revenue 38.84
Operating Expense 29.66
Net Profit 7.88
Net Profit Margin (%) 20.28
Earnings Per Share (EPS) 17.86
EBITDA 11.04
Effective Tax Rate (%) 23.91
Particulars DEC 2023 (Values in Cr)
Revenue 35.66
Operating Expense 29.16
Net Profit 5.40
Net Profit Margin (%) 15.14
Earnings Per Share (EPS) 12.25
EBITDA 8.54
Effective Tax Rate (%) 31.12
Particulars SEP 2023 (Values in Cr)
Revenue 38.29
Operating Expense 29.85
Net Profit 7.32
Net Profit Margin (%) 19.11
Earnings Per Share (EPS) 16.59
EBITDA 10.20
Effective Tax Rate (%) 23.27
Particulars MAR 2024 (Values in Cr)
Revenue 141.97
Operating Expense 111.46
Net Profit 25.98
Net Profit Margin (%) 18.29
Earnings Per Share (EPS) 58.86
EBITDA 37.79
Effective Tax Rate (%) 26.15
Particulars MAR 2023 (Values in Cr)
Revenue 136.75
Operating Expense 109.01
Net Profit 24.61
Net Profit Margin (%) 17.99
Earnings Per Share (EPS) 53.90
EBITDA 35.48
Effective Tax Rate (%) 25.13
Particulars MAR 2022 (Values in Cr)
Revenue 123.98
Operating Expense 99.05
Net Profit 22.30
Net Profit Margin (%) 17.98
Earnings Per Share (EPS) 48.58
EBITDA 32.20
Effective Tax Rate (%) 25.34
Particulars MAR 2021 (Values in Cr)
Revenue 109.29
Operating Expense 91.96
Net Profit 16.50
Net Profit Margin (%) 15.09
Earnings Per Share (EPS) 35.96
EBITDA 24.15
Effective Tax Rate (%) 23.75
Particulars MAR 2020 (Values in Cr)
Revenue 118.89
Operating Expense 101.98
Net Profit 14.87
Net Profit Margin (%) 12.50
Earnings Per Share (EPS) 32.40
EBITDA 23.97
Effective Tax Rate (%) 29.65
Particulars MAR 2024 (Values in Cr)
Book Value / Share 328.42
ROE % 19.44
ROCE % 25.67
Total Debt to Total Equity 0.01
EBITDA Margin 26.62
Particulars MAR 2023 (Values in Cr)
Book Value / Share 277.32
ROE % 20.53
ROCE % 26.04
Total Debt to Total Equity 0.04
EBITDA Margin 25.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 255.77
ROE % 20.66
ROCE % 25.94
Total Debt to Total Equity 0.05
EBITDA Margin 25.97
Particulars MAR 2021 (Values in Cr)
Book Value / Share 214.55
ROE % 18.49
ROCE % 22.77
Total Debt to Total Equity 0.05
EBITDA Margin 22.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 174.32
ROE % 18.89
ROCE % 24.71
Total Debt to Total Equity 0.07
EBITDA Margin 20.16
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 79.19
Total Assets 165.09
Total Liabilities 165.09
Total Equity 144.94
Share Outstanding 4413300
Price to Book Ratio 2.10
Return on Assets (%) 15.73
Return on Capital (%) 17.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 53.80
Total Assets 141.81
Total Liabilities 141.81
Total Equity 122.38
Share Outstanding 4413300
Price to Book Ratio 2.40
Return on Assets (%) 17.35
Return on Capital (%) 19.71
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 49.02
Total Assets 142.94
Total Liabilities 142.94
Total Equity 117.38
Share Outstanding 4589378
Price to Book Ratio 2.22
Return on Assets (%) 15.59
Return on Capital (%) 18.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 56.50
Total Assets 121.18
Total Liabilities 121.18
Total Equity 98.46
Share Outstanding 4589378
Price to Book Ratio 1.86
Return on Assets (%) 13.61
Return on Capital (%) 16.15
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 57.69
Total Assets 104.30
Total Liabilities 104.30
Total Equity 80.00
Share Outstanding 4589378
Price to Book Ratio 1.82
Return on Assets (%) 14.25
Return on Capital (%) 17.82
Particulars MAR 2024 (Values in Cr)
Net Income 25.97
Cash from Operations 16.38
Cash from Investing -0.58
Cash from Financing -7.07
Net change in Cash 0.46
Free Cash Flow 18.94
Particulars MAR 2023 (Values in Cr)
Net Income 24.60
Cash from Operations 25.27
Cash from Investing 2.61
Cash from Financing -21.04
Net change in Cash -1.37
Free Cash Flow 27.38
Particulars MAR 2022 (Values in Cr)
Net Income 22.29
Cash from Operations 16.83
Cash from Investing -1.20
Cash from Financing -5.53
Net change in Cash 2.53
Free Cash Flow 19.88
Particulars MAR 2021 (Values in Cr)
Net Income 16.50
Cash from Operations 25.29
Cash from Investing -18.78
Cash from Financing -0.71
Net change in Cash -0.04
Free Cash Flow 26.43
Particulars MAR 2020 (Values in Cr)
Net Income 14.86
Cash from Operations 20.48
Cash from Investing -2.87
Cash from Financing -10.83
Net change in Cash 1.30
Free Cash Flow 25.03
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 37.68 3.57 502.48 37.54 / 77.70
BLISS GVS PHARMA LTD 173.80 21.75 1.81 1830.67 92.25 / 175.80
CIPLA LTD 1446.35 25.30 4.11 116809.04 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.80 141.25 4.12 1197.25 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2306.65 48.74 23.36 39076.04 1668.20 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 57.02 11.14 502.48 37.54 / 77.70
AMRUTAJAN HEALTH LTD 751.60 45.72 7.29 2172.92 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6636.00 128.88 24.42 16590.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 173.80 22.66 1.78 1830.67 92.25 / 175.80

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1294.00
  • 26 Days 1222.40
  • 10 Days 1270.40
  • 50 Days 1156.90
  • 12 Days 1265.70
  • 100 Days 1092.30
  • 20 Days 1234.00
  • 200 Days 804.10
1299.30
PIVOT
First Resistance 1356.30
Second Resistance 1387.00
Third Resistance 1444.00
First Support 1268.60
Second Support 1211.60
Third Support 1180.90
RSI 67.27
MACD 54.21
Commodity Channel Index (CCI) 162.22
ADX 30.19
Williams % R -2.59

Over 1 Month

down

11.62

Over 3 Months

down

17.60

Over 6 Months

down

62.95

Over 1 Year

down

92.39

Over 3 Years

down

34.45

Over 5 Years

down

27.07

JENBURKT PHARMACEUTICALS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

JENBURKT PHARMACEUTICALS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
53.29
Promoter Holdings
46.7
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Bhuta Holdings Private Limited Shareholding of Promoter and Promoter Group 616128.0 13.96
Jayshree Uttam Bhuta Shareholding of Promoter and Promoter Group 536480.0 12.16
Kalindi Hemendra Bhuta Shareholding of Promoter and Promoter Group 399700.0 9.06
Ashish Uttam Bhuta Shareholding of Promoter and Promoter Group 261127.0 5.92
Nirmala Vinodkumar Daga Public Shareholding 145493.0 3.3
Mahesh Harshad Bhuta Shareholding of Promoter and Promoter Group 67860.0 1.54
Ranjeet Singh Sibia Public Shareholding 65650.0 1.49
Rajiv Garg Public Shareholding 52102.0 1.18
Bhavika Ashish Bhuta Shareholding of Promoter and Promoter Group 51637.0 1.17
Kunti Ketan Gala Shareholding of Promoter and Promoter Group 51278.0 1.16
Parshva Kumar Daga Public Shareholding 46557.0 1.05
Sushila Paraskumar Daga Public Shareholding 46346.0 1.05
Varun Daga Public Shareholding 45450.0 1.03
Bharath C Jain Public Shareholding 45000.0 1.02
Kaushik Daga Public Shareholding 45000.0 1.02
Riddhi Haresh Shroff Shareholding of Promoter and Promoter Group 32240.0 0.73
Jagruti Ketan Bhuta Shareholding of Promoter and Promoter Group 27910.0 0.63
Shivani Haresh Shroff Shareholding of Promoter and Promoter Group 17000.0 0.39
Prakash H Bhuta Shareholding of Promoter and Promoter Group 0.0 0.0

JENBURKT PHARMACEUTICALS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-19 14.4 Final 2023-07-20 Equity shares 2022-07-21 12.0 Final 2022-07-23 Equity shares 2021-08-30 10.2 Final 2021-09-01 Equity shares 2020-03-18 8.1 Interim 2020-03-19 Equity shares 2019-07-22 10.2 Final 2019-07-24 Equity shares 2018-07-23 6.0 Final 2018-07-25 Equity shares 2018-03-27 3.0 Interim 2018-03-28 Equity shares 2017-07-21 8.1 Final 2017-07-25 Equity shares 2016-07-19 0.9 Final 2016-07-21 Equity shares 2016-03-17 6.3 Interim 2016-03-18 Equity shares 2015-08-31 6.3 Final 2015-09-02 Equity shares 2014-09-03 5.1 Final 2014-09-05 Equity shares 2013-09-18 4.2 Final 2013-09-20 Equity shares 2012-07-23 3.5 Final 2012-07-25 Equity shares 2011-07-21 3.5 Final 2011-07-23 Equity shares 2010-07-21 3.0 Final 2010-07-23 Equity shares 2009-07-23 1.8 Final 2009-07-25 Equity shares 2008-07-23 1.25 Final 2008-07-25 Equity shares 2007-07-18 1.25 Final 2007-07-20 Equity shares 2005-08-10 0.0 Final 2005-08-12 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About JENBURKT PHARMACEUTICALS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by JENBURKT PHARMACEUTICALS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Jenburkt Pharmaceuticals Ltd?

Answer Field

The share price of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 1312.30.

What is the Market Cap of Jenburkt Pharmaceuticals Ltd?

Answer Field

The market cap of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 5,79.20 Cr. as of now.

What is the 52 Week High and Low of Jenburkt Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1375.00 and ₹ 643.20.

How to Buy Jenburkt Pharmaceuticals Ltd share?

Answer Field

You can trade in Jenburkt Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Jenburkt Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 90.00%.

What is the Current Share Price of Jenburkt Pharmaceuticals Ltd?

Answer Field

Jenburkt Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1312.30 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Jenburkt Pharmaceuticals Ltd Share?

Answer Field

The market cap of Jenburkt Pharmaceuticals Ltd for NSE ₹ 0.0 & for BSE ₹ 5,79.20 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Jenburkt Pharmaceuticals Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Jenburkt Pharmaceuticals Ltd share is 19.11.

What is the PB ratio of Jenburkt Pharmaceuticals Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Jenburkt Pharmaceuticals Ltd share is 357.46.

How to Buy Jenburkt Pharmaceuticals Ltd Share?

Answer Field

You can trade in Jenburkt Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Jenburkt Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Jenburkt Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jenburkt Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader